Neural Chips for Parkinson's and Epilepsy Attract $5M for London Startup

Jan de Vries · 2026-10-07

London-based MintNeuro just raised €4.4 million ($5 million) to build specialized chips for neural devices—from brain implants to wearables. The funding round was led by Odyssey Ventures, with participation from 33East, JSK Investments, and Alumni Ventures, plus returning backers Empirical Ventures, Jumpspace Ventures, and early investors. ### Why This Matters for Brain Tech If you've ever wondered what powers a brain implant or a neural wearable, it's the chips inside. Today, most developers face a tough choice: use generic components that weren't designed for the human body, or spend years and millions developing custom chips. MintNeuro is changing that. "Every neural device depends on the chips inside it," says Dorian Haci, co-founder and CEO of MintNeuro. "We are building the chips that end that trade-off. This funding moves us from technology validation to commercial scale-up." ### A Surge in Neurotech Investment MintNeuro's raise is part of a bigger wave. In 2026 alone, European neurotech companies have pulled in over €83.9 million ($95 million), according to EU-Startups. That includes: - **ONWARD Medical** (Eindhoven) – €40.6 million ($46 million) for spinal-cord stimulation - **nyra health** (Vienna) – €20 million ($22.7 million) for digital neurorehabilitation - **neuroClues** (France/Belgium) – €10 million ($11.3 million) for neurodiagnostics - **Cerca Magnetics** (UK) – €4.3 million ($4.9 million) for wearable brain imaging Add MintNeuro's round, and the total jumps to roughly €88.3 million ($100 million). Clearly, investors see huge potential in brain-computer interfaces and neural devices. ### The Chip That Could Change Everything Founded in 2022 as a spinout from Imperial College London, MintNeuro develops specialized chips that connect devices to the brain and nervous system. These chips reportedly offer better performance than generic parts, with lower risk, lower cost, and a faster route to market than custom design. The company has already delivered working silicon and hit key milestones with partners like Motif Neurotech and Amber Therapeutics. Earlier this year, MintNeuro signed a multi-year supply agreement with Motif to support a minimally invasive neurostimulator for treatment-resistant depression. ### What Investors Are Saying "Neural devices such as BCIs represent one of the most exciting frontier technology opportunities today," says Michelle Robson, Founding Partner at Odyssey Ventures. "MintNeuro has the technology, market pull, and ambition to become a globally important semiconductor company." Yiannis Eftychiou, co-founder and Partner at 33East, adds: "What stood out to us is the sheer breadth of the hardware opportunity. MintNeuro is solving critical needs for neural implants today, with technology that can extend into wearables and beyond." ### The Road Ahead With this funding, MintNeuro plans to accelerate product launch, expand delivery of pre-release silicon to partners, and grow its international presence—including into Silicon Valley. As neural devices open new ways to understand and treat conditions like Parkinson's and epilepsy, MintNeuro is positioning itself as the semiconductor platform the global neurotech industry builds on. For anyone following EU Inc news and European startup incorporation, this is a clear signal: the intersection of semiconductors and neurotechnology is heating up, and the smart money is paying attention.